A required part of this site could not load. This could be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.
A required part of this site could not load. This could be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.
Palo Alto Investors LP reported a purchase of 41,303 shares of PTC therapeutics (NASDAQ:PTCT) in its SEC filing on February 17, 2026, with an estimated transaction value of $3.00 million…
Client Challenge JavaScript is disabled in your browser. Please enable JavaScript to continue. A required part of this site could not load. This could be due to a browser extension,…
